BLOG
Insights management is never really “finished.” Here’s how medical affairs teams are positioning themselves for continuous improvement.
KOLs outside the traditional physician profile can offer critical insight throughout drug development and launch. Here’s how to include this group in your next ad board.
We examined a year of trend tracking to see what we could learn about where pharma is headed.
Forging ahead without needed insights wastes time, money, and opportunity. How can pharma teams close the insight gap?
In our latest episode, an expert explains why pharma teams must include allied health professionals in their key engagements.
The latest news from our product team includes a dramatic rethinking of how insights are collected and shared.
What’s new in life science, and how should companies respond?
By unlocking real-time, unscripted insights, pharma teams can accelerate strategy. But first, make a plan for assessment and continuous improvement.
How to ensure your data is ‘just right’ for insight gathering.
A concerted effort to center patient feedback brings experts together in a collaborative environment.
